How close are we to gene doping?

Hastings Center Report

Volumn 40, Issue 2, 2010, Pages 20-22

  Friedmann, Theodore ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DOPING; ETHICS; FEMALE; GENE THERAPY; HUMAN; MALE; SPORT; STANDARD;

DOPING IN SPORTS; FEMALE; GENE THERAPY; HUMANS; MALE; SPORTS;

EID: 77952080712     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.1353/hcr.0.0246     Document Type: Article

References (10)

1. J. Tierney, "Let the Games be Doped," New York Times, August 14, 2008;
2. N. Fost, "Let the Doping Begin," New York Times, August 12, 2008;
3. "A Level Playing Field?" Nature 454 (2008): 667.
4. A. Miah, "Enhanced Athletes: It's Only Natural," Washington Post, August 1, 2008.
5. T. Friedmann et al., "Gene Doping and Sport," Science 327 (2010): 647-48.
6. T. Friedmann and R. Roblin, "Gene Therapy for Human Genetic Disease?" Science 175 (1972): 949-55.
7. S. Hacein-Bey-Abina et al., "Sustained Correction of X-Linked Severe Combined Immunodeficiency by Ex Vivo Gene Therapy," New England Journal of Medicine 346 (2002): 1185-93; (Pubitemid 34984579)
8. A. Aiuti et al., "Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency," New England Journal of Medicine 360 (2009): 447-58;
9. A.M. Maguire et al., "Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis," New England Journal of Medicine 358 (2008): 2240-48; (Pubitemid 351724453)
10. N. Cartier, et al., "Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy," Science 326 (2009): 818-23.